Why India needs more research-based life sciences companies
Is the Indian generic pharmaceutical industry one of the major obstacles to fighting endemic health problems in the country? You may begin to think so after reading this article written by Kiran Mazumdar-Shaw in the Economic Times. Ms Mazmudar-Shaw…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.